<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

51% Control Rate Achieved In Phase II Trial of Elderly Patients

60 Minutes Report “Deception at Duke” Wins Peabody Award

Study: Partial Kidney Removal Leads to Greater Survival

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

Two Children Achieve Remission With CD19 Immunotherapy

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

Study: Oncotype DX Score Can Predict Local Recurrence

BRAF Mutation Testing Classifies Indeterminate FNA Samples

NCI CTEP Approved Trials For the Month of March